Kenvue Inc

Q1 Performance: Kenvue reported a 1.2% decline in organic sales for Q1 2025 compared to the previous year, primarily due to destocking in China and strategic investments in pricing and trade spend in the U.S. The company remains on track with its full-year organic sales growth outlook of 2-4%.

Segment Analysis: - Self Care: A marginal growth of 0.3% driven by strong performances in allergy, digestive health, and smoking cessation, compensating for declines in cough, cold, and flu products. - Skin Health and Beauty: Experienced a 4.8% decline in organic sales, impacted by destocking in China and a poor sun season in Latin America, although the EMEA region showed resilience with organic growth. - Essential Health: Organic sales were flat due to competitive pressures and ongoing destocking.

Challenges: The company faces uncertainties stemming from external factors such as tariffs, FX impacts, and a volatile macroeconomic environment. For 2025, the estimated impact of tariffs is approximately $150 million.